John Anthony Atala , MD (born 1958) - director of the Institute of Regenerative Medicine Wake Forest, head of the department of urology at the Wake Forest School of Medicine in North Carolina [2] , professor of advanced cell technology at the Institute of Regenerative Medicine of the First Moscow State Medical University named after IM Sechenov [ 3] . One of the pioneers of regenerative medicine [4] .
| Anthony Atala | |
|---|---|
| Date of Birth | |
| Place of Birth | |
| A country | |
| Occupation | |
Content
- 1 Biography
- 2 Main publications
- 3 See also
- 4 notes
- 5 Links
Biography
Born in Peru. He graduated from the University of Miami with a bachelor of psychology. Later he graduated from the School of Medicine at the University of Louisville with a specialization in urology [5] . In 1990-1992 He continued his studies at the Clinical Residency at Harvard Medical School with a clinical base at the Boston Children's Hospital, where he studied with the world-famous pediatric urological surgeons Alan Retik and Hardy Hendren. He was director of the Laboratory of Tissue Engineering and Cell Therapy at the Boston Children's Hospital [6] , where he was engaged in the cultivation of human tissues and organs to replace damaged ones due to diseases or defects.
Atala continued his work in tissue engineering and 3D organ printing at Wake Forest Baptist Medical Center (WFBMC) in 2004 [7] , where he led the team that raised the first bioengineered bladder implanted in humans [8] .
In 2011, he was elected a member of the Institute of Medicine of the National Academy of Sciences . Dr. Anthony Atala was named The Doctor of the Year by Scientific American for his contributions to the study of cell, tissue, and organ regeneration [9] .
Editor-in-chief of the journals Stem Cells-Translational Medicine (Scopus, SJR 1.64), Current Stem Cell Research and Therapy (Scopus, SJR 0.68) and Therapeutic Advances in Urology (Scopus, SJR 0.89).
Main publications
- Atala, A., Danilevskiy, M., Lyundup, A., Glybochko, P., Butnaru, D., Vinarov, A., & Yoo, JJ (2017). The potential role of tissue ‐ engineered urethral substitution: clinical and preclinical studies . Journal of tissue engineering and regenerative medicine , 11 (1), 3-19. doi: 10.1002 / term.2112
- Murphy, SV, & Atala, A. (2014). 3D bioprinting of tissues and organs . Nature biotechnology , 32 (8) , 773-785. doi: 10.1038 / nbt.2958
- De Coppi, P., Bartsch, G., Siddiqui, MM, Xu, T., Santos, CC, Perin, L., ... & Furth, ME (2007). Isolation of amniotic stem cell lines with potential for therapy . Nature biotechnology , 25 (1) , 100-106. doi: 10.1038 / nbt1274
- Atala, A., Bauer, SB, Soker, S., Yoo, JJ, & Retik, AB (2006). Tissue-engineered autologous bladders for patients needing cystoplasty . The Lancet , 367 (9518) , 1241-1246. doi: 10.1016 / S0140-6736 (06) 68438-9
See also
- Organ cultivation
- Regenerative medicine
- Tissue engineering
Notes
- ↑ LIBRIS
- ↑ "Anthony Atala, MD, Professor and Director - WFIRM . " wfirm.org . Retrieved September 28, 2017.
- ↑ Sechenov University Institute of Regenerative Medicine Archival copy of October 4, 2017 on the Wayback Machine . Retrieved 4-10-2017.
- ↑ "Scientist at Work: Anthony Atala. A Tissue Engineer Sows Cells and Grows Organs" Archived May 25, 2017. . Retrieved September 28, 2017.
- ↑ Svoboda, Elizabeth (December 2006). "The Organ Farmer" . Popular Science . 269 (6): 101.
- ↑ "Archived copy" . Archived from the original on 2006-12-30. Retrieved 2007-01-21.
- ↑ "News Releases" Archived October 11, 2009 on the Wayback Machine . www1.wfubmc.edu . Retrieved September 28, 2017.
- ↑ Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB (April 2006). "Tissue-engineered autologous bladders for patients needing cystoplasty." Lancet . 367 : 1241–6. PMID 16631879 . doi: 10.1016 / S0140-6736 (06) 68438-9 .
- ↑ "Anthony Atala, MD, Director and Chair" Archived October 24, 2014 on the Wayback Machine . Wake Forest Institute of Regenerative Medicine. Retrieved November 17, 2014.
Links
- Anthony Atala, MD, Director and Chair of Wake Forest School of Medicine (Personal Profile)